Meghraj Suryawanshi | Pharmacology and Pharmaceutical Science | Best Researcher Award

Prof. Dr. Meghraj Suryawanshi | Pharmacology and Pharmaceutical Science | Best Researcher Award

Assistant Professor | Sandip Institute of Pharmaceutical Sciences | India

Dr. Meghraj Vivekanand Suryawanshi is an accomplished Associate Professor and Training & Placement Coordinator at the Sandip Institute of Pharmaceutical Sciences, Nashik, specializing in pharmaceutics. He holds a Ph.D. in Pharmaceutics from Jaipur National University, an M.Pharm in Pharmaceutics from R.C. Patel Institute of Pharmaceutical Education and Research, a B.Pharm from Sinhgad Institutes of Pharmaceutical Sciences, and an MBA in Hospital Administration. Dr. Suryawanshi has extensive professional experience, serving as a Ph.D. research scholar, Assistant Professor at multiple institutions, and co-founder and CTO of AllWell Nutritech LLP, where he contributed to start-up incubation and entrepreneurial initiatives. He has supervised numerous undergraduate and postgraduate students and actively coordinated academic and administrative programs including training and placement, entrepreneurship, library management, and examination coordination. His research focuses on advanced drug delivery systems, formulation development, and pharmaceutical technology, with a significant body of publications contributing to national and international journals. Dr. Suryawanshi has also engaged in editorial responsibilities and professional memberships that support scholarly exchange and innovation in the pharmaceutical sciences. Recognized for his dedication to research, education, and mentorship, he has been instrumental in fostering academic excellence, student development, and industry collaboration, demonstrating leadership, scientific rigor, and a commitment to advancing the field of pharmaceutics at both institutional and broader professional levels.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Suryawanshi, I., Srinidhi, S., Singh, S., Kalia, R., Kunchala, R. K., Mudavath, S. L., …. (2021). Downshifting and upconversion dual mode emission from lanthanide doped GdPO4 nanorods for unclonable anti-counterfeiting. Materials Today Communications, 26, 102144.

2. Patil, S. M., Suryawanshi, M. V., Chandanshive, V. V., Kurade, M. B., Govindwar, S. P., …. (2020). Regeneration of textile wastewater deteriorated microbial diversity of soil microcosm through bioaugmentation. Chemical Engineering Journal, 380, 122533.

3. Suryawanshi, M. V., Gujarathi, P. P., Mulla, T., & Bagban, I. (2024). Hypericum perforatum: A comprehensive review on pharmacognosy, preclinical studies, putative molecular mechanism, and clinical studies in neurodegenerative disorders. Naunyn-Schmiedeberg’s Archives of Pharmacology, 397(6), 3803–3818.

4. Bhagat, D. S., Suryawanshi, I. V., Gurnule, W. B., Sawant, S. S., & Chavan, P. B. (2021). Greener synthesis of CuO nanoparticles for enhanced development of latent fingerprints. Materials Today: Proceedings, 36, 747–750.

5. Suryawanshi, I., Kalia, R., Kunchala, R. K., Mudavath, S. L., & Naidu, B. S. (2022). Detection of latent fingerprints using luminescent Gd0.95Eu0.05PO4 nanorods. Journal of Rare Earths, 40(4), 572–578.

RAJWINDER KAUR | MEDICINAL CHEMISTRY | Best Researcher Award

Dr. RAJWINDER KAUR | MEDICINAL CHEMISTRY | Best Researcher Award

PROFESSOR, CHITKARA UNIVERSITY, India

Dr. Rajwinder Kaur is an esteemed professor and researcher with over 16 years of experience in pharmaceutical education and research. She currently holds the position of Assistant Dean for the PharmD Program at Chitkara University, Rajpura. Her career is marked by significant contributions to the field of pharmaceutical chemistry, focusing on drug design and development. Dr. Kaur has received numerous awards and honors for her dedication and excellence in the field, including the Young Scientist Award and the Best Teacher Award.

Education 🎓

Dr. Rajwinder Kaur has an extensive academic background in pharmaceutical sciences. She completed her B. Pharm with distinction from A.S.B.A.S.J.S.M. College of Pharmacy in 2004 and her M. Pharm from Rajiv Academy for Pharmacy in 2007. She earned her Ph.D. in Pharmaceutical Chemistry from Panjab University, Chandigarh in 2014. Additionally, she holds multiple postgraduate diplomas, including in Clinical Trial, Research & Administration, and Guidance and Counselling.

Professional Experience 🏢

Dr. Kaur’s professional journey spans various prestigious institutions. She began as a lecturer at Polytechnic Institute for Women, Ropar, and later joined Panjab University as a Project Fellow and CSIR-SRF. She has also served as a Women Scientist under the DST-WOS(A) scheme. Her recent roles include Assistant Professor at Chandigarh University, and Associate Professor, Professor, and Assistant Dean at Chitkara University.

Research Interests 🔬

Dr. Kaur’s research interests lie in computer-aided drug design and the discovery of new chemical entities. Her focus areas include the development of novel adenosine receptor ligands, anti-inflammatory agents, antiasthmatics, and neuroprotective compounds. She also explores natural products for treating diseases like dengue and cerebral ischemic injury.

Awards 🏆

Dr. Kaur has been recognized with several prestigious awards, including:

  • Young Scientist Award (Women in Pharmaceutical Sciences) at Chitkara University in 2023
  • Best Teacher Award by Chandigarh University in 2016
  • Dr. Harpal Singh Buttar and Harinder Kaur Buttar Young Scientist Award in 2013
  • DST Women Scientist (WOS-A) by the Department of Science and Technology, India

Profile 🌐

Google Scholar Profile: Dr. Rajwinder Kaur

Publications Top Notes 📚

Target protein degradation by protacs: A budding cancer treatment strategy. Pharmacology & Therapeutics, 2023. DOI: 10.1016/j.pharmthera.2023.108525

Evolving Advances in the Cosmetic Use of Probiotics and Postbiotics: Health, Regulatory and Marketing Aspects. Curr Pharm Biotechnol, 2023. DOI: 10.2174/1389201024666230703115732

Combating Microbial Infections Using Metal-Based Nanoparticles as Potential Therapeutic Alternatives. Antibiotics, 2023. DOI: 10.3390/antibiotics12050909

Antibiotics in Paediatrics: A Boon or a Bane? Anti-Infective Agents, 2023, 21(2), 1-17.

Synthesis and Pharmacological Evaluation of Promising Coumarin Methyl ester/di/tri/terta Peptide Derivatives. ECS Transactions, 2022, 107(1), 6747–6761.

In Silico Evaluation of Reserpine as Potential Anti-Candidal Agent. J. Pharm. Tech. Res. Management, 2021, 9(1), 1–5.

Importance of Pharmacovigilance in Ayurveda. J. Pharm. Tech. Res. Management, 2021, 9(2), 87–97.

Targeting natural products against SARS-CoV-2. Environmental Science and Pollution Research, 2022, 29(28), 42404–42432.